Adverse Effects
CIPN in Breast Cancer: Do Subjective and Objective Measures Correlate?
December 11, 2018Researchers sought to determine how subjective measures of CIPN correlated with objective measures of CIPN.
Patients, Physicians Do Not Recognize Fatigue the Same
December 10, 2018A worldwide survey reveals that despite similar perceptions on symptom burden of ITP, patients and physicians do not agree on the effect of fatigue on quality of life.
ADT May Up Risk for Heart Failure in Prostate Cancer Patients
December 10, 2018Heart failure risk was found to be higher for androgen deprivation therapy users in a propensity score-matched analysis.
Lung Cancer-Specific Distress Screening Tool Not Needed But Has Potential Benefit
November 29, 2018Using focus groups, researchers evaluated patient-reported psychosocial consequences of lung cancer to determine if a lung cancer-specific distress screening instrument would benefit these patients.
Report From Childhood Cancer Survivor Study Identifies Long-Term Risks for VTE
November 16, 2018Assessment of long-term risks for VTE based on data from almost 30,000 childhood cancer survivors and siblings, with approximately 21 years of follow-up.
Hodgkin Lymphoma Survivorship Marked by Periods of Actionable Distress
November 12, 2018A retrospective evaluation of patients treated at a tertiary cancer center demonstrated that patients with Hodgkin lymphoma experienced periods of actionable distress in survivorship, despite a low overall distress burden.
Commission Seeks Standardized Adverse Event Assessments in Hematologic Malignancies
November 08, 2018A snapshot of an international Commission's report on the issues inherent with adverse event reports of hematologic malingnancies in clinical trials.
ASCO, SITC Release Recommendations for Clinical Trial Reporting of Immunotherapy Adverse Events
November 05, 2018As immunotherapies gain a stronger foothold as a treatment option for cancer, ASCO and SITC convened a panel to develop recommendations to ensure consistent and efficient clinical trial reporting in immuno-oncology.
Predictive Role of Skin Rash in Advanced Pancreatic Cancer Patients Treated With Gemcitabine Plus Erlotinib: A Systematic Review and Meta-analysis
November 02, 2018[OncoTargets and Therapy] In this systematic review and meta-analysis, researchers sought to determine the predictive value of skin rash in patients with advanced pancreatic cancer treated with gemcitabine plus erlotinib.
Chemotherapy Side Effects in Women vs Men: Broader Range, More Severe
October 30, 2018An analysis of pooled data from 4 randomized controlled clinical trials revealed that male and female patients experience different chemotherapy side effects and at different severities, according to a poster presented at ESMO 2018 Congress.
Strength and Hope for Women in the Mist of Cancer
October 22, 2018A review of the most feared effects of breast cancer treatment and resources to recommend to patients coping with these effects.
Prospective Study Measures Cognitive, Treatment Effects in Older Breast Cancer Survivors
October 22, 2018Thinking and Living With Cancer (TLC) sought to determine the effects of breast cancer treatment and age on cognitive function in older breast cancer survivors over time.
Immune Checkpoint Inhibitor Therapy May Affect Thyroid Function
October 22, 2018A review of medical records revealed that thyroid function may be affected by immune checkpoint inhibitor therapy, and these patients should undergo thyroid function tests, especially during the first 8 weeks of therapy.
Hypofractionated Radiotherapy After Conservative Surgery May Increase Low-intermediate Grade Late Fibrosis in Breast Cancer Patients
October 19, 2018[Breast Cancer: Targets and Therapy] Researchers sought to determine the incidence of subcutaneous side effects in patients with early-stage breast cancer treated with AHF-RT vs standard fractionated RT after breast conserving surgery.
Self-Care Toolkits Ease Negative PostSurgery Experiences for Patients With Breast Cancer
October 10, 2018Self-care toolkits were found to reduce pain and other negative postsurgical experiences for women undergoing surgical procedures for breast cancer.
Assessment Tool for Immunotherapy Side Effects
October 04, 2018My patient is receiving immunotherapy. What is the best tool for assessing side effects?
Anxiety, Depression in Prostate Cancer: Managing Psychosocial Effects in Male Patients
October 03, 2018A review of how emotions, social perceptions, and physical effects influence coping skills for men with prostate cancer.
CNS Tumors in Childhood: Predicting Successful Independence in Adult Life
October 01, 2018Researchers at St Jude Children's Research Hospital sought to determine what indicators in survivors of CNS tumors can predict the survivor's ability to live independently as an adult.
Infections in Primary Immune Thrombocytopenia Associated With Low Platelet Count
September 26, 2018A retrospective study of platelet- and infection-related data from patients with ITP revealed the influence platelet levels have on infections as well as efficacy of transfusions.
Immune Checkpoint Inhibitors: A Review of Side Effects, Their Causes and Incidence
September 25, 2018A multicenter research team determined the incidence and type of fatal toxic effects associated with immune checkpoint inhibitors.
Estimating Quality of Life Based on Cumulative Drug Toxicity in Colorectal Cancer
September 24, 2018Results of a study in which more than 100 patients with metastatic colorectal cancer completed EORTC-QLQ-C30 suggests an association between assessment of cumulative drug toxicities and predictions of quality of life for patients undergoing first-line chemotherapy for the disease.
Pulmonary Toxicity Increased in Pediatric Hodgkin Lymphoma Treated With Brentuximab Vedotin
September 13, 2018A retrospective study evaluated the efficacy vs pulmonary toxicity of brentuximab vedotin for relapsed or refractory Hodgkin lymphoma in pediatric patients.
Late Lower Cranial Neuropathy Worsens Symptom Burden in Oropharyngeal Cancer Survivors
September 10, 2018Researchers conducted a cross-sectional study to determine the incidence and effect of late lower cranial neuropathies on survivors of oropharyngeal cancers.
SD-101 May Enhance the Effectiveness of Immunotherapy in Melanoma
August 31, 2018In this phase 1b study, researchers evaluated the efficacy of immunotherapy with pembrolizumab to treat advanced melanoma.
Pre-HSCT Conditioning May Improve Physical Functioning in Hematologic Cancers
August 29, 2018In this retrospective study, researchers assessed the outcomes of 88 patients with hematologic disease who underwent HSCT.
Nonmyeloablative/Reduced-Intensity Conditioning May Reduce Mucositis in HCT
August 16, 2018Researchers sought to determine if NMA or reduced-intensity conditioning with busulfan improved severity/duration of oral mucositis compared with myeloablative conditioning in patients with hematologic cancer undergoing HCT.
FDA, EU Approvals Sought for Split Dose Regimen of Daratumumab for Multiple Myeloma
August 14, 2018The manufacturer of daratumumab, a CD38-directed antibody for the treatment of multiple myeloma, has submitted a sBLA and a type II variation to the US FDA and European Medicines Agency, respectively, for approval of a split dosing regimen.
8 Hours of Bedrest May Be Ideal After Intrathecal Chemotherapy in Hematologic Cancers
August 14, 2018In an open-label study, researchers sought to determine the optimal amount of bed rest after intrathecal chemotherapy for patients with hematologic cancers.
Assessing Direct Costs of Treatment-Related Adverse Events in Advanced Melanoma
August 10, 2018In a systematic review, researchers explored the financial burden of treating grade 3 to 4 adverse events associated with melanoma and its treatment.
Healthcare Use, Economic Burden Greater With Cancer-Related Opioid-Induced Constipation
August 03, 2018Use of opioids to manage cancer-related pain may have adverse effects of its own that can have a significant impact on healthcare use among patients with cancer.
Sign Up for Free e-newsletters
ONA Articles
- Proscription on Antiperspirant Use During Radiotherapy: Does the Advice Still Apply?
- PFS, OS Improved With Sequential Rituximab/Bendamustine, Rituximab/Cytarabine in Untreated Mantle Cell Lymphoma
- ADT May Up Risk for Heart Failure in Prostate Cancer Patients
- Patients, Physicians Do Not Recognize Fatigue the Same
- CIPN in Breast Cancer: Do Subjective and Objective Measures Correlate?
- Smartphone App Improves Management of Cancer-Related Pain, Anxiety
- Counseling Patients on Oral Chemotherapy
- Proscription on Antiperspirant Use During Radiotherapy: Does the Advice Still Apply?
- Lung Cancer-Specific Distress Screening Tool Not Needed But Has Potential Benefit
- Prophylaxis Improves Postchemotherapy Nausea/Vomiting Frequency, Hospitalizations
- Steering Patients Toward Reliable Internet Resources
- Postmastectomy Breast Reconstruction Safe in Older Women With Breast Cancer
- CIPN in Breast Cancer: Do Subjective and Objective Measures Correlate?
- Risk of Breast Cancer Higher for African American Female Veterans
- Patients, Physicians Do Not Recognize Fatigue the Same
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
| Bone Cancer | Regimens | Drugs |
| Brain Cancer | Regimens | Drugs |
| Breast Cancer | Regimens | Drugs |
| Endocrine Cancer | Regimens | Drugs |
| Gastrointestinal Cancer | Regimens | Drugs |
| Genitourinary Cancer | Regimens | Drugs |
| Gynecologic Cancer | Regimens | Drugs |
| Head and Neck Cancer | Regimens | Drugs |
| Hematologic Cancer | Regimens | Drugs |
| Lung Cancer | Regimens | Drugs |
| Other Cancers | Regimens | |
| Rare Cancers | Regimens | |
| Skin Cancer | Regimens | Drugs |